Institute of Infectious Diseases and Infection Control, Jena University Hospital, Stoystraße 3, 07743, Jena, Germany.
Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany.
Crit Care. 2024 Aug 29;28(1):283. doi: 10.1186/s13054-024-05076-x.
Long-Covid (LC), Post-Sepsis-Syndrome (PSS) and Post-Intensive-Care-Syndrome (PICS) show remarkable overlaps in their clinical presentation. Nevertheless, it is unclear if they are distinct syndromes, which may co-occur in the same patient, or if they are three different labels to describe similar symptoms, assigned on the basis on patient history and professional perspective of the treating physician. Therefore, we reviewed the current literature on the relation between LC, PSS and PICS. To date, the three syndromes cannot reliably be distinguished due similarities in clinical presentation as they share the cognitive, psychological and physical impairments with only different probabilities of occurrence and a heterogeneity in individual expression. The diagnosis is furthermore hindered by a lack of specific diagnostic tools. It can be concluded that survivors after COVID-19 sepsis likely have more frequent and more severe consequences than patients with milder COVID-19 courses, and that are some COVID-19-specific sequelae, e.g. an increased risk for venous thromboembolism in the 30 days after the acute disease, which occur less often after sepsis of other causes. Patients may profit from leveraging synergies from PICS, PSS and LC treatment as well as from experiences gained from infection-associated chronic conditions in general. Disentangling molecular pathomechanisms may enable future targeted therapies that go beyond symptomatic treatment.
长新冠(LC)、败血症后综合征(PSS)和重症监护后综合征(PICS)在临床表现上有显著的重叠。然而,目前尚不清楚它们是否是不同的综合征,这些综合征是否可能同时存在于同一患者中,或者它们是否是基于患者病史和治疗医生的专业观点而分配的类似症状的三个不同标签。因此,我们回顾了关于 LC、PSS 和 PICS 之间关系的现有文献。迄今为止,由于临床表现相似,这三种综合征无法可靠地区分,因为它们都有认知、心理和身体障碍,只是发生的概率不同,个体表现存在异质性。诊断还受到缺乏特定诊断工具的阻碍。可以得出结论,COVID-19 败血症幸存者可能比 COVID-19 轻症患者有更多且更严重的后果,并且 COVID-19 有一些特定的后遗症,例如急性疾病后 30 天内静脉血栓栓塞的风险增加,而其他原因引起的败血症则较少发生。患者可能会从 PICS、PSS 和 LC 治疗的协同作用以及从一般感染相关慢性疾病中获得的经验中受益。分解分子病理机制可能会为未来超越对症治疗的靶向治疗提供可能。